Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Mogamulizumab can cause hair loss and skin rashes.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

JAK inhibitors may help improve symptoms in adults with APECED.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Anti-CD19 therapy may help treat SLE and NMOSD.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.